Paris
France
7
2020-06-04
7
2021-11-02
These are the the leading inventors for applications assigned to ONXEO:
ONXEO based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Use of a combination of Dbait molecule and PARP inhibitors to treat cancer
#2 | 2020-05-21 ✅ Patent 11,266,614 granted on 2022-03-08Oral formulations of belinostat
#3 | 2019-10-17 ✅ Patent 10,765,758 granted on 2020-09-08Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
#4 | 2019-03-28 ✅ Patent 10,821,128 granted on 2020-11-03Treatment of cancer by systemic administration of Dbait molecules
#5 | 2018-12-20 ✅ Patent 10,563,197 granted on 2020-02-18Use of a combination of Dbait molecule and PARP inhibitors to treat cancer
#6 | 2017-10-19 ✅ Patent 10,363,317 granted on 2019-07-30Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
#7 | 2016-11-24 ✅ Patent 9,687,557 granted on 2017-06-27Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates
Also check out ONXEO's (Paris, France) applicant profile with 7 patent applications submitted.
373698 ⎘